IgE-mediated sensitization to malassezia in atopic dermatitis: More common in male patients and in head and neck type

Dermatitis

Volumn 25, Issue 3, 2014, Pages 120-126

  Brodská, Petra ^a,b   Panzner, Petr ^a   Pizinger, Karel ^a   Schmid Grendelmeier, Peter ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; FUNGUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGEN SPECIFICITY; ARTICLE; ATOPIC DERMATITIS; ATOPY; CHILD; CLINICAL FEATURE; DERMATITIS; DISEASE SEVERITY; ECZEMA; FEMALE; HEAD AND NECK ATOPIC DERMATITIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALASSEZIA; MALASSEZIA GLOBOSA; MALASSEZIA RESTRICTA; MALASSEZIA SYMPODIALIS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; SENSITIZATION; SEX RATIO; DERMATITIS, ATOPIC; DERMATOMYCOSES; GERMANY; HEAD; IMMUNOLOGY; MIDDLE AGED; NECK; PATCH TEST; PROCEDURES; PROGNOSIS; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; VERY ELDERLY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; CHILD; DERMATITIS, ATOPIC; DERMATOMYCOSES; FEMALE; GERMANY; HEAD; HUMANS; IMMUNOGLOBULIN E; MALASSEZIA; MALE; MIDDLE AGED; NECK; PATCH TESTS; PROGNOSIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SEX FACTORS;

EID: 84902654105     PISSN: 17103568     EISSN: 21625220     Source Type: Journal    
DOI: 10.1097/DER.0000000000000040     Document Type: Article

References (48)

1. Zhang E, Tanaka T, Tajima M, et al. Anti-Malassezia-specific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: relationship between the level of specific IgE antibody and the colonization frequency of cutaneous Malassezia species and clinical severity. J Allergy (Cairo) 2011;2011:645670.
2. Bergmann RL, Edenharter G, Bergmann KE, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998;28(8):965-970.
3. Bozek A, Fisher A, Filipowska B, et al. Clinical features and immunological markers of atopic dermatitis in elderly patients. Int Arch Allergy Immunol 2012;157(4):372-378.
4. Katsarou A, Armenaka M. Atopic dermatitis in older patients: particular points. J Eur Acad Dermatol Venereol 2011;25(1):12-18.
5. Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated withMalassezia species. J Am Acad Dermatol 2004;51(5):785-798.
6. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 2012;132(3 Pt 2):949-963.
7. EPAAC Study Group. de Benedictis FM, Franceschini F, Hill D, et al. The allergic sensitization in infants with atopic eczema from different countries. Allergy 2009;64(2):295-303.
8. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010;58(1):1-7.
9. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 2004;15(1):86-88.
10. Vakirlis E, Lazaridou E, Tzellos TG, et al. Investigation of cytokine levels and their association with SCORAD index in adults with acute atopic dermatitis. J Eur Acad Dermatol Venereol 2011;25(4):409-416.
11. Salt BH, Boguniewicz M, Leung DY. Severe refractory atopic dermatitis in adults is highly atopic. J Allergy Clin Immunol 2007;119(2):508-509.
12. Williams H, FlohrC.How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006;118(1):209-213.
13. Fölster-HolstR, PapeM, BussYL, et al. Lowprevalence of the intrinsic formof atopic dermatitis among adult patients. Allergy 2006;61(5):629-632.
14. Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 2005;53(2):338-340.
15. Kaminishi K, Soma Y, Kawa Y, et al. Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 2002;29(1):19-25.
16. Cardona ID, Cho SH, Leung DY. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 2006;7(5):273-279.
17. Cotterill JA, Cunliffe WJ,Williamson B, et al. Age and sex variation in skin surface lipid composition and sebum excretion rate. Br J Dermatol 1972; 87(4):333-340.
18. Darabi K, Hostetler SG, Bechtel MA, et al. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009;60(1):125-136.
19. Wong AW, Hon EK, Zee B. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. Int J Dermatol 2008;47(2):187-191.
20. Saki N, Jowkar F, Alyaseen S. Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis. J Dermatolog Treat 2013;24(6):447-449.
21. Selander C, Zargari A, Möllby R, et al. Higher pH level, corresponding to that on the skin of patients with atopic eczema, stimulates the release of Malassezia sympodialis allergens. Allergy 2006;61(8):1002-1008.
22. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002;15(4): 545-563.
23. Gupta AK, Kohli Y, Summerbell RC, et al. Quantitative culture ofMalassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001;39(3):243-251.
24. Nakabayashi A, Sei Y, Guillot J. Identification ofMalassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000;38(5):337-341.
25. SandströmFalk MH, Tengvall Linder M, Johansson C, et al. The prevalence ofMalassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005;85(1):17-23.
26. Sugita T, Tajima M, Amaya M, et al. Genotype analysis of Malassezia restricta as the major cutaneous flora in patients with atopic dermatitis and healthy subjects. Microbiol Immunol 2004;48(10):755-759.
27. Sugita T, Tajima M, Tsubuku H, et al. Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using real-time PCR. Microbiol Immunol 2006;50(7):549-552.
28. Schmid-Grendelmeier P, Scheynius A, Crameri R. The role of sensitization to Malassezia sympodialis in atopic eczema. Chem Immunol Allergy 2006; 91:98-109.
29. Johansson C, SandströmMH, Bartosik J, et al. Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol 2003;148(3):479-488.
30. Kato H, Sugita T, Ishibashi Y, et al. Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzyme-linked immunosorbent assay. Microbiol Immunol 2006;50(11):851-856.
31. Casagrande BF, Flückiger S, Linder MT, et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol 2006;126(11):2414-2421.
32. Waersted A, Hjorth N. Pityrosporum orbiculareVa pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol Suppl (Stockh) 1985;114:146-148.
33. Bayrou O, Pecquet C, Flahault A, et al. Head and neck atopic dermatitis and Malassezia-furfur-specific IgE antibodies. Dermatology 2005;211(2):107-113.
34. Kim TY, Jang IG, Park YM, et al. Head and neck dermatitis: the role of Malassezia furfur, topical steroid use and environmental factors in its causation. Clin Exp Dermatol 1999;24(3):226-231.
35. Devos SA, van der Valk PG. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy 2000;55(11):1056-1058.
36. Newell L, Polak ME, Perera J, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol 2013;133(10):2372-2380.
37. Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 1999;40(2 Pt 1):187-193.
38. Ramirez de Knott HM, McCormick TS, Kalka K, et al. Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern. Contact Dermatitis 2006;54(2):92-99.
39. Lintu P, Savolainen J, Kalimo K, et al. Stability of Pityrosporum ovale allergens during storage. Clin Exp Allergy 1998;28(4):486-490.
40. Scalabrin DM, Bavbek S, Perzanowski MS, et al. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 1999;104(6):1273-1279.
41. Lange L, Alter N, Keller T, et al. Sensitization to Malassezia in infants and children with atopic dermatitis: prevalence and clinical characteristics. Allergy 2008;63(4):486-487.
42. Kekki OM, Scheynius A, Poikonen S, et al. Sensitization to Malassezia in children with atopic dermatitis combined with food allergy. Pediatr Allergy Immunol 2013;24(3):244-249.
43. Sandström Falk MH, Faergemann J. Atopic dermatitis in adults: does it disappear with age? Acta Derm Venereol 2006;86(2):135-139.
44. Figueredo LA, Cafarchia C, Desantis S, et al. Biofilm formation of Malassezia pachydermatis from dogs. Vet Microbiol 2012;160:126-131.
45. Pedrosa AF, Lisboa C, Rodrigues AG. Malassezia infections: a medical conundrum. J Am Acad Dermatol 2014. Epub ahead of print 2014 Feb
46. Bäck O, Bartosik J. Systemic ketoconazole for yeast allergic patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2001;15:34-38.
47. Svejgaard E, Larsen PO, Deleuran M, et al. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004;18:445-449.
48. Selander C, Engblom C, Nilsson G, et al. TLR2/MyD88-dependent and-independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol 2009;182(7): 4208-4216.